Ontology highlight
ABSTRACT: Background
The genetic determinants of heart failure (HF) and response to medical therapy remain unknown. We hypothesized that identifying genetic variants of HF that associate with response to medical therapy would elucidate the genetic basis of cardiac function.Objectives
This study sought to identify genetic variations associated with response to HF therapy.Methods
This study compared extremes of response to medical therapy in 866 HF patients using a genome-wide approach that informed the systems-based design of a customized single nucleotide variant array. The effect of genotype on gene expression was measured using allele-specific luciferase reporter assays. Candidate gene transcription-deficient mice underwent echocardiography and treadmill exercise. The ability of the target gene agonist to rescue mice from chemically-induced HF was assessed with echocardiography.Results
Of 866 HF patients, 136 had an ejection fraction improvement of 20% attributed to resynchronization (n = 83), revascularization (n = 7), tachycardia resolution (n = 2), alcohol cessation (n = 1), or medications (n = 43). Those with the minor allele for rs7767652, upstream of hypocretin (orexin) receptor-2 (HCRTR2), were less likely to have improved left ventricular function (odds ratio: 0.40 per minor allele; p = 3.29 × 10(-5)). In a replication cohort of 798 patients, those with a minor allele for rs7767652 had a lower prevalence of ejection fraction >35% (odds ratio: 0.769 per minor allele; p = 0.021). In an HF model, HCRTR2-deficient mice exhibited poorer cardiac function, worse treadmill exercise capacity, and greater myocardial scarring. Orexin, an HCRTR2 agonist, rescued function in this HF mouse model.Conclusions
A systems approach identified a novel genetic contribution to human HF and a promising therapeutic agent efficacious in an HF model.
SUBMITTER: Perez MV
PROVIDER: S-EPMC8991813 | biostudies-literature | 2015 Dec
REPOSITORIES: biostudies-literature
Perez Marco V MV Pavlovic Aleksandra A Shang Ching C Wheeler Matthew T MT Miller Clint L CL Liu Jing J Dewey Frederick E FE Pan Stephen S Thanaporn Porama K PK Absher Devin D Brandimarto Jeffrey J Salisbury Heidi H Chan Khin K Mukherjee Rupak R Konadhode Roda P RP Myers Richard M RM Sedehi Daniel D Scammell Thomas E TE Quertermous Thomas T Cappola Thomas T Ashley Euan A EA
Journal of the American College of Cardiology 20151201 22
<h4>Background</h4>The genetic determinants of heart failure (HF) and response to medical therapy remain unknown. We hypothesized that identifying genetic variants of HF that associate with response to medical therapy would elucidate the genetic basis of cardiac function.<h4>Objectives</h4>This study sought to identify genetic variations associated with response to HF therapy.<h4>Methods</h4>This study compared extremes of response to medical therapy in 866 HF patients using a genome-wide approa ...[more]